Gemcitabine, paclitaxel, and garboplatin for advanced non-small-cell lung cancer

ONCOLOGY

Volumn 14, Issue 7 SUPPL. 4, 2000, Pages 31-34

  Greco, F Anthony ^a   Burris III, Howard A ^a   Hainsworth, John D ^a  

^a SARAH CANNON RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; PACLITAXEL;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DOSE RESPONSE; FEMALE; HUMAN; LEUKOCYTE COUNT; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; SQUAMOUS CELL CARCINOMA; THROMBOCYTE COUNT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LEUKOCYTE COUNT; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; PLATELET COUNT;

EID: 0034218402     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Hainsworth JD, Thompson DS, Greco FA: Paclitaxel by 1-hour infusion: An active drug in mctastatic non-small-cell lung cancer. J Clin Oncol 13:1609-1614, 1995.
2. Francis P, Rigas J, Kris M, et al: Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer. J Clin Oncol 12:1232-1237, 1994.
3. Fossella F, Lee J, Berille J, et al: Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small-cell lung cancer. J Clin Oncol 22:22-29, 1995.